Benitec Biopharma (BNTC) Change in Receivables (2019 - 2025)
Benitec Biopharma (BNTC) posted Change in Receivables of -$123000.0 for Q4 2025, down 310.0% sequentially from -$30000.0 in Q3 2025, and down 154.42% YoY from $226000.0 in Q4 2024.
Powered by 
Analysis
Benitec Biopharma (BNTC) Change in Receivables (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Change in Receivables for 6 years, with the latest figure at -$123000.0 in Q4 2025.
- Quarterly Change in Receivables fell 154.42% year-over-year to -$123000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$350000.0 (down 298.86% YoY) and the FY2025 annual result came in at -$197000.0, down 211.93% from the prior year.
- Change in Receivables retreated to -$123000.0 in Q4 2025 per BNTC's latest filing, from -$30000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $226000.0 in Q4 2024 and troughed at -$226000.0 in Q3 2024.
- A 4-year average of -$15909.1 and a median of -$7000.0 in 2021 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 757.14% in 2022, down 771.43% in 2022.
- Over 4 years, Change in Receivables stood at -$7000.0 in 2021, then surged by 757.14% to $46000.0 in 2022, then surged by 391.3% to $226000.0 in 2024, then slumped by 154.42% to -$123000.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$123000.0, -$30000.0, and $29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | -123,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -123,000.00 |
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Sep 30, 2024 | -226,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | -27,000.00 |
| Jun 30, 2020 | 98,000.00 |
| Mar 31, 2020 | -928,000.00 |
| Dec 31, 2019 | -592,000.00 |
| Sep 30, 2019 | -974,000.00 |